Drug profile · INN
tacrine hydrochloride
COGNEX
tacrine hydrochloride (COGNEX) is a cholinesterases; ache & bche inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — tacrine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tacrine hydrochloride (COGNEX) is a cholinesterases; ache & bche inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cholinesterases; ACHE & BCHE inhibitor
Primary target: Cholinesterases; ACHE & BCHE
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tacrine hydrochloride?
tacrine hydrochloride (COGNEX) is a cholinesterases; ache & bche inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tacrine hydrochloride?
COGNEX is a marketed brand name for tacrine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tacrine hydrochloride?
tacrine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.